Medical Care
Global Transfusion-dependent Anemia Treatment Market Research Report 2025
- Mar 11, 25
- ID: 14024
- Pages: 65
- Figures: 65
- Views: 1
The global market for Transfusion-dependent Anemia Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Transfusion-dependent anemia refers to a condition in which individuals require regular blood transfusions to maintain an adequate level of hemoglobin and red blood cells. This condition often arises in certain types of anemias, where the body is unable to produce a sufficient number of red blood cells or hemoglobin, leading to chronic and severe anemia. The most common example is thalassemia, a genetic disorder characterized by reduced or absent synthesis of hemoglobin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Transfusion-dependent Anemia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transfusion-dependent Anemia Treatment.
The Transfusion-dependent Anemia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transfusion-dependent Anemia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transfusion-dependent Anemia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bluebird bio, Inc.
Novartis AG
Takeda Pharmaceuticals
Acceleron Pharma, Inc.
Celgene Corporation
Segment by Type
Cell Therapy
Medication
Others
Segment by Application
Hospital
Ambulatory Surgery Center
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transfusion-dependent Anemia Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Transfusion-dependent anemia refers to a condition in which individuals require regular blood transfusions to maintain an adequate level of hemoglobin and red blood cells. This condition often arises in certain types of anemias, where the body is unable to produce a sufficient number of red blood cells or hemoglobin, leading to chronic and severe anemia. The most common example is thalassemia, a genetic disorder characterized by reduced or absent synthesis of hemoglobin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Transfusion-dependent Anemia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transfusion-dependent Anemia Treatment.
The Transfusion-dependent Anemia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transfusion-dependent Anemia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transfusion-dependent Anemia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bluebird bio, Inc.
Novartis AG
Takeda Pharmaceuticals
Acceleron Pharma, Inc.
Celgene Corporation
Segment by Type
Cell Therapy
Medication
Others
Segment by Application
Hospital
Ambulatory Surgery Center
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transfusion-dependent Anemia Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transfusion-dependent Anemia Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Therapy
1.2.3 Medication
1.2.4 Others
1.3 Market by Application
1.3.1 Global Transfusion-dependent Anemia Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transfusion-dependent Anemia Treatment Market Perspective (2020-2031)
2.2 Global Transfusion-dependent Anemia Treatment Growth Trends by Region
2.2.1 Global Transfusion-dependent Anemia Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transfusion-dependent Anemia Treatment Historic Market Size by Region (2020-2025)
2.2.3 Transfusion-dependent Anemia Treatment Forecasted Market Size by Region (2026-2031)
2.3 Transfusion-dependent Anemia Treatment Market Dynamics
2.3.1 Transfusion-dependent Anemia Treatment Industry Trends
2.3.2 Transfusion-dependent Anemia Treatment Market Drivers
2.3.3 Transfusion-dependent Anemia Treatment Market Challenges
2.3.4 Transfusion-dependent Anemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transfusion-dependent Anemia Treatment Players by Revenue
3.1.1 Global Top Transfusion-dependent Anemia Treatment Players by Revenue (2020-2025)
3.1.2 Global Transfusion-dependent Anemia Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Transfusion-dependent Anemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transfusion-dependent Anemia Treatment Revenue
3.4 Global Transfusion-dependent Anemia Treatment Market Concentration Ratio
3.4.1 Global Transfusion-dependent Anemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transfusion-dependent Anemia Treatment Revenue in 2024
3.5 Global Key Players of Transfusion-dependent Anemia Treatment Head office and Area Served
3.6 Global Key Players of Transfusion-dependent Anemia Treatment, Product and Application
3.7 Global Key Players of Transfusion-dependent Anemia Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transfusion-dependent Anemia Treatment Breakdown Data by Type
4.1 Global Transfusion-dependent Anemia Treatment Historic Market Size by Type (2020-2025)
4.2 Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Type (2026-2031)
5 Transfusion-dependent Anemia Treatment Breakdown Data by Application
5.1 Global Transfusion-dependent Anemia Treatment Historic Market Size by Application (2020-2025)
5.2 Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transfusion-dependent Anemia Treatment Market Size (2020-2031)
6.2 North America Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025)
6.4 North America Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transfusion-dependent Anemia Treatment Market Size (2020-2031)
7.2 Europe Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025)
7.4 Europe Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transfusion-dependent Anemia Treatment Market Size (2020-2031)
8.2 Asia-Pacific Transfusion-dependent Anemia Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transfusion-dependent Anemia Treatment Market Size (2020-2031)
9.2 Latin America Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025)
9.4 Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transfusion-dependent Anemia Treatment Market Size (2020-2031)
10.2 Middle East & Africa Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bluebird bio, Inc.
11.1.1 Bluebird bio, Inc. Company Details
11.1.2 Bluebird bio, Inc. Business Overview
11.1.3 Bluebird bio, Inc. Transfusion-dependent Anemia Treatment Introduction
11.1.4 Bluebird bio, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025)
11.1.5 Bluebird bio, Inc. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Transfusion-dependent Anemia Treatment Introduction
11.2.4 Novartis AG Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025)
11.2.5 Novartis AG Recent Development
11.3 Takeda Pharmaceuticals
11.3.1 Takeda Pharmaceuticals Company Details
11.3.2 Takeda Pharmaceuticals Business Overview
11.3.3 Takeda Pharmaceuticals Transfusion-dependent Anemia Treatment Introduction
11.3.4 Takeda Pharmaceuticals Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025)
11.3.5 Takeda Pharmaceuticals Recent Development
11.4 Acceleron Pharma, Inc.
11.4.1 Acceleron Pharma, Inc. Company Details
11.4.2 Acceleron Pharma, Inc. Business Overview
11.4.3 Acceleron Pharma, Inc. Transfusion-dependent Anemia Treatment Introduction
11.4.4 Acceleron Pharma, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025)
11.4.5 Acceleron Pharma, Inc. Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Transfusion-dependent Anemia Treatment Introduction
11.5.4 Celgene Corporation Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025)
11.5.5 Celgene Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transfusion-dependent Anemia Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Therapy
1.2.3 Medication
1.2.4 Others
1.3 Market by Application
1.3.1 Global Transfusion-dependent Anemia Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transfusion-dependent Anemia Treatment Market Perspective (2020-2031)
2.2 Global Transfusion-dependent Anemia Treatment Growth Trends by Region
2.2.1 Global Transfusion-dependent Anemia Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transfusion-dependent Anemia Treatment Historic Market Size by Region (2020-2025)
2.2.3 Transfusion-dependent Anemia Treatment Forecasted Market Size by Region (2026-2031)
2.3 Transfusion-dependent Anemia Treatment Market Dynamics
2.3.1 Transfusion-dependent Anemia Treatment Industry Trends
2.3.2 Transfusion-dependent Anemia Treatment Market Drivers
2.3.3 Transfusion-dependent Anemia Treatment Market Challenges
2.3.4 Transfusion-dependent Anemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transfusion-dependent Anemia Treatment Players by Revenue
3.1.1 Global Top Transfusion-dependent Anemia Treatment Players by Revenue (2020-2025)
3.1.2 Global Transfusion-dependent Anemia Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Transfusion-dependent Anemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transfusion-dependent Anemia Treatment Revenue
3.4 Global Transfusion-dependent Anemia Treatment Market Concentration Ratio
3.4.1 Global Transfusion-dependent Anemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transfusion-dependent Anemia Treatment Revenue in 2024
3.5 Global Key Players of Transfusion-dependent Anemia Treatment Head office and Area Served
3.6 Global Key Players of Transfusion-dependent Anemia Treatment, Product and Application
3.7 Global Key Players of Transfusion-dependent Anemia Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transfusion-dependent Anemia Treatment Breakdown Data by Type
4.1 Global Transfusion-dependent Anemia Treatment Historic Market Size by Type (2020-2025)
4.2 Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Type (2026-2031)
5 Transfusion-dependent Anemia Treatment Breakdown Data by Application
5.1 Global Transfusion-dependent Anemia Treatment Historic Market Size by Application (2020-2025)
5.2 Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Transfusion-dependent Anemia Treatment Market Size (2020-2031)
6.2 North America Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025)
6.4 North America Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transfusion-dependent Anemia Treatment Market Size (2020-2031)
7.2 Europe Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025)
7.4 Europe Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transfusion-dependent Anemia Treatment Market Size (2020-2031)
8.2 Asia-Pacific Transfusion-dependent Anemia Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transfusion-dependent Anemia Treatment Market Size (2020-2031)
9.2 Latin America Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025)
9.4 Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transfusion-dependent Anemia Treatment Market Size (2020-2031)
10.2 Middle East & Africa Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bluebird bio, Inc.
11.1.1 Bluebird bio, Inc. Company Details
11.1.2 Bluebird bio, Inc. Business Overview
11.1.3 Bluebird bio, Inc. Transfusion-dependent Anemia Treatment Introduction
11.1.4 Bluebird bio, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025)
11.1.5 Bluebird bio, Inc. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Transfusion-dependent Anemia Treatment Introduction
11.2.4 Novartis AG Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025)
11.2.5 Novartis AG Recent Development
11.3 Takeda Pharmaceuticals
11.3.1 Takeda Pharmaceuticals Company Details
11.3.2 Takeda Pharmaceuticals Business Overview
11.3.3 Takeda Pharmaceuticals Transfusion-dependent Anemia Treatment Introduction
11.3.4 Takeda Pharmaceuticals Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025)
11.3.5 Takeda Pharmaceuticals Recent Development
11.4 Acceleron Pharma, Inc.
11.4.1 Acceleron Pharma, Inc. Company Details
11.4.2 Acceleron Pharma, Inc. Business Overview
11.4.3 Acceleron Pharma, Inc. Transfusion-dependent Anemia Treatment Introduction
11.4.4 Acceleron Pharma, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025)
11.4.5 Acceleron Pharma, Inc. Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Transfusion-dependent Anemia Treatment Introduction
11.5.4 Celgene Corporation Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025)
11.5.5 Celgene Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Transfusion-dependent Anemia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Medication
Table 4. Key Players of Others
Table 5. Global Transfusion-dependent Anemia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Transfusion-dependent Anemia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Transfusion-dependent Anemia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Transfusion-dependent Anemia Treatment Market Share by Region (2020-2025)
Table 9. Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Transfusion-dependent Anemia Treatment Market Share by Region (2026-2031)
Table 11. Transfusion-dependent Anemia Treatment Market Trends
Table 12. Transfusion-dependent Anemia Treatment Market Drivers
Table 13. Transfusion-dependent Anemia Treatment Market Challenges
Table 14. Transfusion-dependent Anemia Treatment Market Restraints
Table 15. Global Transfusion-dependent Anemia Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Transfusion-dependent Anemia Treatment Market Share by Players (2020-2025)
Table 17. Global Top Transfusion-dependent Anemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transfusion-dependent Anemia Treatment as of 2024)
Table 18. Ranking of Global Top Transfusion-dependent Anemia Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Transfusion-dependent Anemia Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Transfusion-dependent Anemia Treatment, Headquarters and Area Served
Table 21. Global Key Players of Transfusion-dependent Anemia Treatment, Product and Application
Table 22. Global Key Players of Transfusion-dependent Anemia Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Transfusion-dependent Anemia Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Transfusion-dependent Anemia Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Bluebird bio, Inc. Company Details
Table 48. Bluebird bio, Inc. Business Overview
Table 49. Bluebird bio, Inc. Transfusion-dependent Anemia Treatment Product
Table 50. Bluebird bio, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025) & (US$ Million)
Table 51. Bluebird bio, Inc. Recent Development
Table 52. Novartis AG Company Details
Table 53. Novartis AG Business Overview
Table 54. Novartis AG Transfusion-dependent Anemia Treatment Product
Table 55. Novartis AG Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025) & (US$ Million)
Table 56. Novartis AG Recent Development
Table 57. Takeda Pharmaceuticals Company Details
Table 58. Takeda Pharmaceuticals Business Overview
Table 59. Takeda Pharmaceuticals Transfusion-dependent Anemia Treatment Product
Table 60. Takeda Pharmaceuticals Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025) & (US$ Million)
Table 61. Takeda Pharmaceuticals Recent Development
Table 62. Acceleron Pharma, Inc. Company Details
Table 63. Acceleron Pharma, Inc. Business Overview
Table 64. Acceleron Pharma, Inc. Transfusion-dependent Anemia Treatment Product
Table 65. Acceleron Pharma, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025) & (US$ Million)
Table 66. Acceleron Pharma, Inc. Recent Development
Table 67. Celgene Corporation Company Details
Table 68. Celgene Corporation Business Overview
Table 69. Celgene Corporation Transfusion-dependent Anemia Treatment Product
Table 70. Celgene Corporation Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025) & (US$ Million)
Table 71. Celgene Corporation Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
Table 75. Authors List of This Report
List of Figures
Figure 1. Transfusion-dependent Anemia Treatment Picture
Figure 2. Global Transfusion-dependent Anemia Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transfusion-dependent Anemia Treatment Market Share by Type: 2024 VS 2031
Figure 4. Cell Therapy Features
Figure 5. Medication Features
Figure 6. Others Features
Figure 7. Global Transfusion-dependent Anemia Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Transfusion-dependent Anemia Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Ambulatory Surgery Center Case Studies
Figure 11. Others Case Studies
Figure 12. Transfusion-dependent Anemia Treatment Report Years Considered
Figure 13. Global Transfusion-dependent Anemia Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Transfusion-dependent Anemia Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Transfusion-dependent Anemia Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Transfusion-dependent Anemia Treatment Market Share by Players in 2024
Figure 17. Global Top Transfusion-dependent Anemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transfusion-dependent Anemia Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Transfusion-dependent Anemia Treatment Revenue in 2024
Figure 19. North America Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Transfusion-dependent Anemia Treatment Market Share by Country (2020-2031)
Figure 21. United States Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Transfusion-dependent Anemia Treatment Market Share by Country (2020-2031)
Figure 25. Germany Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Transfusion-dependent Anemia Treatment Market Share by Region (2020-2031)
Figure 33. China Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Transfusion-dependent Anemia Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Transfusion-dependent Anemia Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Bluebird bio, Inc. Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2020-2025)
Figure 49. Novartis AG Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2020-2025)
Figure 50. Takeda Pharmaceuticals Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2020-2025)
Figure 51. Acceleron Pharma, Inc. Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2020-2025)
Figure 52. Celgene Corporation Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global Transfusion-dependent Anemia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Medication
Table 4. Key Players of Others
Table 5. Global Transfusion-dependent Anemia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Transfusion-dependent Anemia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Transfusion-dependent Anemia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Transfusion-dependent Anemia Treatment Market Share by Region (2020-2025)
Table 9. Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Transfusion-dependent Anemia Treatment Market Share by Region (2026-2031)
Table 11. Transfusion-dependent Anemia Treatment Market Trends
Table 12. Transfusion-dependent Anemia Treatment Market Drivers
Table 13. Transfusion-dependent Anemia Treatment Market Challenges
Table 14. Transfusion-dependent Anemia Treatment Market Restraints
Table 15. Global Transfusion-dependent Anemia Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Transfusion-dependent Anemia Treatment Market Share by Players (2020-2025)
Table 17. Global Top Transfusion-dependent Anemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transfusion-dependent Anemia Treatment as of 2024)
Table 18. Ranking of Global Top Transfusion-dependent Anemia Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Transfusion-dependent Anemia Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Transfusion-dependent Anemia Treatment, Headquarters and Area Served
Table 21. Global Key Players of Transfusion-dependent Anemia Treatment, Product and Application
Table 22. Global Key Players of Transfusion-dependent Anemia Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Transfusion-dependent Anemia Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Transfusion-dependent Anemia Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Bluebird bio, Inc. Company Details
Table 48. Bluebird bio, Inc. Business Overview
Table 49. Bluebird bio, Inc. Transfusion-dependent Anemia Treatment Product
Table 50. Bluebird bio, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025) & (US$ Million)
Table 51. Bluebird bio, Inc. Recent Development
Table 52. Novartis AG Company Details
Table 53. Novartis AG Business Overview
Table 54. Novartis AG Transfusion-dependent Anemia Treatment Product
Table 55. Novartis AG Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025) & (US$ Million)
Table 56. Novartis AG Recent Development
Table 57. Takeda Pharmaceuticals Company Details
Table 58. Takeda Pharmaceuticals Business Overview
Table 59. Takeda Pharmaceuticals Transfusion-dependent Anemia Treatment Product
Table 60. Takeda Pharmaceuticals Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025) & (US$ Million)
Table 61. Takeda Pharmaceuticals Recent Development
Table 62. Acceleron Pharma, Inc. Company Details
Table 63. Acceleron Pharma, Inc. Business Overview
Table 64. Acceleron Pharma, Inc. Transfusion-dependent Anemia Treatment Product
Table 65. Acceleron Pharma, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025) & (US$ Million)
Table 66. Acceleron Pharma, Inc. Recent Development
Table 67. Celgene Corporation Company Details
Table 68. Celgene Corporation Business Overview
Table 69. Celgene Corporation Transfusion-dependent Anemia Treatment Product
Table 70. Celgene Corporation Revenue in Transfusion-dependent Anemia Treatment Business (2020-2025) & (US$ Million)
Table 71. Celgene Corporation Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
Table 75. Authors List of This Report
List of Figures
Figure 1. Transfusion-dependent Anemia Treatment Picture
Figure 2. Global Transfusion-dependent Anemia Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Transfusion-dependent Anemia Treatment Market Share by Type: 2024 VS 2031
Figure 4. Cell Therapy Features
Figure 5. Medication Features
Figure 6. Others Features
Figure 7. Global Transfusion-dependent Anemia Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Transfusion-dependent Anemia Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Ambulatory Surgery Center Case Studies
Figure 11. Others Case Studies
Figure 12. Transfusion-dependent Anemia Treatment Report Years Considered
Figure 13. Global Transfusion-dependent Anemia Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Transfusion-dependent Anemia Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Transfusion-dependent Anemia Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Transfusion-dependent Anemia Treatment Market Share by Players in 2024
Figure 17. Global Top Transfusion-dependent Anemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transfusion-dependent Anemia Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Transfusion-dependent Anemia Treatment Revenue in 2024
Figure 19. North America Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Transfusion-dependent Anemia Treatment Market Share by Country (2020-2031)
Figure 21. United States Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Transfusion-dependent Anemia Treatment Market Share by Country (2020-2031)
Figure 25. Germany Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Transfusion-dependent Anemia Treatment Market Share by Region (2020-2031)
Figure 33. China Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Transfusion-dependent Anemia Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Transfusion-dependent Anemia Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Transfusion-dependent Anemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Bluebird bio, Inc. Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2020-2025)
Figure 49. Novartis AG Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2020-2025)
Figure 50. Takeda Pharmaceuticals Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2020-2025)
Figure 51. Acceleron Pharma, Inc. Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2020-2025)
Figure 52. Celgene Corporation Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2020-2025)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232